Publications: Prof. Dr. med. B. Manger
- Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial. Lancet. 2024;403(10429): 850-859
- Tixagevimab/cilgavimab for the prevention of COVID-19 in vaccine-refractory patients with autoimmune diseases: a prospective cohort study. Rheumatology (Oxford). 2024;63(5): 1377-1383
- ["Rheuma (be-)greifen"- A multimodal teaching concept to improve rheumatology education for medical students]. Z Rheumatol. 2024;83(3): 186-193
- [Survey on the working, training, and research conditions of resident physicians in internistic and rheumatological continuing education-BEWUSST]. Z Rheumatol. 2024;83(4): 257-268
- Survey on the working, training, and research conditions of resident physicians in internistic and rheumatological continuing education-BEWUSST. Z Rheumatol. 2024;83(Suppl 1): 31-39
- Clinical Images: Increased bone metabolism in secondary hyperparathyroidism. Arthritis Rheumatol. 2023;75(6):
- Effective and safe treatment of anti-CD38 therapy in systemic lupus erythematosus-associated refractory cerebral vasculitis induces immune tolerance. Rheumatology (Oxford). 2023;62(2): e21-e23
- Physical Function of RA patients Tapering Treatment-A Post Hoc Analysis of the Randomized Controlled RETRO Trial. J Clin Med. 2023;12(11):
- CD19-targeted CAR T cells in refractory antisynthetase syndrome. Lancet. 2023;401(10379): 815-818
- Misdiagnosis of polymyositis in a young female patient with occult limb-girdle muscular dystrophy. Rheumatol Adv Pract. 2023;7(2):
- Morbus Castleman in der rheumatologischen Praxis Z Rheumatol. 2023;():
- [Rheumatology training positions in Germany]. Z Rheumatol. 2023;82(7): 539-551
- Impact of Cytokine Inhibitor Therapy on the Prevalence, Seroconversion Rate, and Longevity of the Humoral Immune Response Against SARS-CoV-2 in an Unvaccinated Cohort. Arthritis Rheumatol. 2022;74(5): 783-790
- Efficacy and safety of SARS-CoV-2 revaccination in non-responders with immune-mediated inflammatory disease. Ann Rheum Dis. 2022;81(7): 1023-1027
- Treatment of refractory hypocomplementaemic urticarial vasculitis syndrome progressing to systemic lupus erythematosus with belimumab. Clin Exp Rheumatol. 2022;40(4): 854-855
- Humoral and Cellular Immune Responses to SARS-CoV-2 Infection and Vaccination in Autoimmune Disease Patients With B Cell Depletion. Arthritis Rheumatol. 2022;74(1): 33-37
- Three generations of suffering: cryopyrin-associated periodic syndrome with NLRP3 mutation in a family. J Dtsch Dermatol Ges. 2022;20(1): 110-112
- [Development of quality standards for patients with rheumatoid arthritis for use in Germany]. Z Rheumatol. 2022;81(9): 744-759
- Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease: a prospective cohort study. Lancet Rheumatol.. 2022;4(9): e614-e625
- Re-exposure with a TNF inhibitor bio-similar was well tolerated and led to sustained control of psoriatic arthritis after allergic reaction to the TNF inhibitor bio-originator. Rheumatol Adv Pract. 2022;6(3):
- Neutralizing monoclonal antibodies against SARS-CoV-2 for COVID-19 pneumonia in a rituximab treated patient with systemic sclerosis-A case report and literature review. Front Med (Lausanne). 2022;9():
- Effects of casirivimab/imdevimab on systemic and mucosal immunity against SARS-CoV-2 in B-cell depleted patients with autoimmune rheumatic diseases refractory to vaccination. RMD Open. 2022;8(1):
- Rare meets rarer: anti-synthetase syndrome in a patient with facio-scapulo-humeral muscular dystrophy. Rheumatology (Oxford). 2022;61(12): e368-e370
- Lymph node and pulmonary tuberculosis during upadacitinib treatment in a psoriatic arthritis patient. Rheumatol Adv Pract. 2022;6(2):
- Augmented neutralization of SARS-CoV-2 Omicron variant by boost vaccination and monoclonal antibodies. Eur J Immunol. 2022;52(6): 970-977
- Clinical Images: Tissue remodeling in autoimmune statin-induced necrotizing autoimmune myopathy. ACR Open Rheumatol. 2022;4(10): 835-836
- Clinical Images: Voriconazole-induced synovitis, enthesitis, and periostitis. Arthritis Rheumatol. 2022;74(7):
- Pseudoacrocyanosis: a case for telemedicine in rheumatology. RMD Open. 2022;8(2):
- [The rubric "Pioneers of rheumatology" becomes "Milestones of rheumatology"]. Z Rheumatol. 2022;81(2): 145-146
- Advanced machine learning for predicting individual risk of flares in rheumatoid arthritis patients tapering biologic drugs. Arthritis Res Ther. 2021;23(1):
- SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases. Ann Rheum Dis. 2021;80(10): 1312-1316
- IgG4-related fasciitis. Rheumatology (Oxford). 2021;61(1): e11-e12
- Resolution of vascular inflammation in patients with new-onset giant cell arteritis: data from the RIGA study. Rheumatology (Oxford). 2021;60(8): 3851-3861
- Does methotrexate influence COVID-19 infection? Case series and mechanistic data. Arthritis Res Ther. 2021;23(1):
- Sustained clinical remission under infliximab/rituximab combination therapy in a patient with granulomatosis with polyangiitis. Auto Immun Highlights. 2021;12(1):
- Autoinflammation leading to autoimmunity in adult-onset Still's disease: more than simple coincidence? Eur J Med Res. 2021;26(1):
- Contrary immediate effect of abatacept on skin and joint manifestations in psoriatic arthritis. Rheumatology (Oxford). 2021;60(9): e312-e313
- [Severe Hepatitis E virus infection in a patient with rheumatoid arthritis treated with baricitinib]. Z Rheumatol. 2021;80(10): 980-983
- CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus. N Engl J Med. 2021;385(6): 567-569
- [80 milestones in rheumatology from 80 years. II. 1961-1980]. Z Rheumatol. 2021;80(6): 506-514
- [80 milestones in rheumatology from 80 years- I. 1940-1960]. Z Rheumatol. 2021;80(6): 497-505
- TREATMENT TAPERING AND WITHDRAWAL IN RHEUMATOID ARTHRITIS WITH STABLE REMISSION - FINAL ANALYSIS OF THE RETRO STUDY Ann Rheum Dis. 2021;80 Suppl 1(): 194-195
- Joachim Robert Kalden: one of the founders of autoimmunity research and immunotherapy Ann Rheum Dis. 2021;80(6): 682-684
- Treatment tapering and stopping in patients with rheumatoid arthritis in stable remission (RETRO): a multicentre, randomised, controlled, open-label, phase 3 trial Lancet Rheumatol.. 2021;3(11): E767-E777
- [Model curriculum of the German Society for Rheumatology for advanced training in the discipline internal medicine and rheumatology]. Z Rheumatol. 2021;80(7): 688-691
- ELDERLY PATIENTS ARE NOT AT INCREASED RISK OF SERIOUS INFECTIONS WHEN RECEIVING BDMARDS OR JAK INHIBITORS COMPARED TO CSDMARD TREATMENT Ann Rheum Dis. 2021;80 Suppl 1(): 64-65
- About the Development of clinical Rheumatology in the Federal Republic of Germany after World War II Aktuelle Rheumatol. 2021;46(03): 241-242
- Differenzialdiagnose Ruckenschmerzen mit Entzundungsparametern: Fallvorstellung: Manifestation einer CPPD als Crowned Dens Syndrom mit Befall peripherer Gelenke Aktuelle Rheumatol. 2021;46(01): 76-79
- Model curriculum of the German society for Rheumatology for advanced training in the discipline internal medicine and rheumatology. English version. Z Rheumatol. 2021;80(Suppl 2): 64-67
- Reactive arthritis and cutaneous vasculitis after SARS-CoV-2 infection. Rheumatology (Oxford). 2021;60(1): 479-480
- Johann Lucas Schoenlein (1793-1864): impact without publications Ann Rheum Dis. 2021;80(2): 140-142
- Long-term B-lymphocyte depletion and remission of granulomatosis with polyangiitis after two courses of rituximab treatment. Rheumatology (Oxford). 2021;60(5): e162-e164
- Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging. Ann Rheum Dis. 2020;79(11): 1485-1491
- Massive nodulous lesions on hands and feet in a RA patient and improvement under baricitinib treatment. RMD Open. 2020;6(3):
- Patients Receiving Cytokine Inhibitors Have Low Prevalence of SARS-CoV-2 Infection Arthritis Rheumatol. 2020;72 Suppl 10():
- Rheumatic Paraneoplastic Syndromes Aktuelle Rheumatol. 2020;45(06): 531-534
- Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion. Nat Commun. 2020;11(1):
- Calcium pyrophosphate deposition disease induced inflammatory back pain. Rheumatology (Oxford). 2020;59(2): 456-456
- COVID-19 revisiting inflammatory pathways of arthritis. Nat Rev Rheumatol. 2020;16(8): 465-470
- Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis. Rheumatology (Oxford). 2020;59(8): 1916-1926
- Corrigendum to: Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis. Rheumatology (Oxford). 2020;59(8): 2191-2191
- Serio - Side Effect Registry in Immuno-Oncology Oncology Research and Treatment. 2020;43(): 231-231
- NO INCREASED RISK OF FALLS IN PATIENTS TREATED WITH BIOLOGICS COMPARED TO THOSE UNDER CSDMARDS Ann Rheum Dis. 2020;79 Suppl 1(): 974-974
- SERIO - Side Effect Registry Immuno-Oncology Side Effect Registry for rare, severe and complex Side Effects of Immunotherapy J Dtsch Dermatol Ges. 2020;18 Suppl 2(): 14-15
- Effects of Conventional Uric Acid-Lowering Therapy on Monosodium Urate Crystal Deposits Arthritis Rheumatol. 2020;72(1): 150-156
- Hypophosphatasia is associated with nonspecific Symptoms Z Rheumatol. 2019;78(6): 496-496
- Rheumatologic Manifestations of Hemoglobinopathies Z Rheumatol. 2019;78(6): 496-496
- Depression as comorbidity of rheumatoid arthritis Z Rheumatol. 2019;78(3): 243-248
- NO DIFFERENCE IN TREATMENT CONTINUATION OF DIFFERENT BIOLOGICS IN ELDERLY PATIENTS > 70 YEARS COMPARED TO YOUNGER PATIENTS <= 65 YEARS Ann Rheum Dis. 2019;78(): 1123-1123
- HIGHER EXPRESSION OF SIGLEC-7/9 ON GRANULOCYTES AND MONOCYTES HAS A PROTECTIVE ROLE IN RHEUMATOID ARTHRITIS Ann Rheum Dis. 2019;78(): A65-A66
- [Erdheim-Chester disease : An important differential diagnosis and its main symptoms]. Z Rheumatol. 2019;78(1): 66-71
- PHYSICAL FUNCTION IN RA PATIENTS IN REMISSION UNDERGOING TAPERING AND/OR STOPPING OF DMARDS Ann Rheum Dis. 2019;78(): 321-322
- Novel Developments in Primary Immunodeficiencies (PID)-a Rheumatological Perspective Curr Rheumatol Rep. 2019;21(10):
- Factors Associated with Persistent Drug-free Remission in Patients with Rheumatoid Arthritis Arthritis Rheumatol. 2019;71():
- Prediction of Disease Relapses by Multi-biomarker Disease Activity Score and Autoantibody Status in RA Patients Tapering DMARD Treatment in Stable Remission Arthritis Rheumatol. 2019;71():
- SIZE MATTERS - EXTENT OF MONOSODIUM URATE DEPOSITS BUT NOT SERUM URATE LEVEL PREDICTS COMPLETE RESOLUTION OF MONOSODIUM URATE CRYSTAL DEPOSITS IN PATIENTS WITH GOUT Ann Rheum Dis. 2019;78(): 1295-1296
- Chondrocalcinosis: idiopathic or manifestation of rare metabolic diseases? Orthopade. 2019;48(11): 949-956
- Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout Ann Rheum Dis. 2019;78(11): 1592-1600
- FACTORS ASSOCIATED WITH PERSISTENT DRUG-FREE REMISSION IN PATIENTS WITH RHEUMATOID ARTHRITIS Ann Rheum Dis. 2019;78(): 730-730
- No Difference in Treatment Continuation of Different Biologics in Elderly Patients > 70 Years Compared to Younger Patients <= 65 Years Arthritis Rheumatol. 2019;71():
- Cost-effective Tapering Algorithm in Patients with Rheumatoid Arthritis: Combination of Multibiomarker Disease Activity Score and Autoantibody Status. J Rheumatol. 2019;46(5): 460-466
- Microscopic polyangiitis after alemtuzumab treatment in relapsing-remitting MS. Neurol Neuroimmunol Neuroinflamm. 2018;5(5):
- Neutrophilic Dermatoses - Classification and Pathophysiology Z Rheumatol. 2018;77(5): 350-350
- LOOSING DAS28-ESR, BUT STAYING IN BOOLEAN REMISSION-IS IT POSSIBLE? DATA FROM THE PROSPECTIVE, RANDOMISED RETRO TRIAL ON RHEUMATOID ARTHRITIS PATIENTS IN STABLE REMISSION Ann Rheum Dis. 2018;77(): 1307-1308
- THE PROGNOSIS OF HEART FAILURE IN PATIENTS WITH RHEUMATOID ARTHRITIS Ann Rheum Dis. 2018;77(): 291-292
- Rheumatic paraneoplastic syndromes - A clinical link between malignancy and autoimmunity. Clin Immunol. 2018;186(): 67-70
- The value of 18F-FDG-PET/CT in identifying the cause of fever of unknown origin (FUO) and inflammation of unknown origin (IUO): data from a prospective study. Ann Rheum Dis. 2018;77(1): 70-77
- Hard palate hyperpigmentation-a rare side effect of antimalarials. Arthritis Rheumatol. 2018;70(1): 152
- Unilateral plantar erythema nodosum in sarcoidosis. Arthritis Rheumatol. 2018;70(2):
- Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs. Ann Rheum Dis. 2017;76(2): 399-407
- [The first biologic for rheumatoid arthritis: factors influencing the therapeutic decision]. Z Rheumatol. 2017;76(3): 210-218
- Gout mimicking rheumatoid arthritis. Semin Arthritis Rheum. 2017;46(4): e15
- Fever of unknown origin, giant cell arteritis, and aortic dissection. Z Rheumatol. 2017;76(1): 83-86
- [Evidence-based recommendations for diagnostics and treatment of gouty arthritis in the specialist sector : S2e guidelines of the German Society of Rheumatology in cooperation with the AWMF]. Z Rheumatol. 2017;76(2): 118-124
- Development of three-dimensional prints of arthritic joints for supporting patients' awareness to structural damage. Arthritis Res Ther. 2017;19(1): 34
- Serious adverse events and the risk of stroke in patients with rheumatoid arthritis: results from the German RABBIT cohort. Ann Rheum Dis. 2017;76(9): 1583-1590
- Aortic dissection and fever: cause or consequence. Z Rheumatol. 2017;76(6): 550-551
- Cardiovascular Comorbidity in Inflammatory Rheumatological Conditions. Dtsch Arztebl Int. 2017;114(12): 197-203
- Pancreatic Panniculitis and Polyarthritis. Curr Rheumatol Rep. 2017;19(10): 62
- Long-term Combination Therapy with Anti-TNF plus Vedolizumab Induces and Maintains Remission in Therapy-refractory Ulcerative Colitis. Am J Gastroenterol. 2017;112(10): 1621-1623